159 related articles for article (PubMed ID: 22094106)
1. Albendazole sensitizes cancer cells to ionizing radiation.
Patel K; Doudican NA; Schiff PB; Orlow SJ
Radiat Oncol; 2011 Nov; 6():160. PubMed ID: 22094106
[TBL] [Abstract][Full Text] [Related]
2. Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts.
Laird JH; Lok BH; Ma J; Bell A; de Stanchina E; Poirier JT; Rudin CM
Clin Cancer Res; 2018 Oct; 24(20):5143-5152. PubMed ID: 29945991
[No Abstract] [Full Text] [Related]
3. Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy.
Helfrich BA; Gao D; Bunn PA
Lung Cancer; 2018 Apr; 118():148-154. PubMed ID: 29571994
[TBL] [Abstract][Full Text] [Related]
4. Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo.
Khan AJ; Wall B; Ahlawat S; Green C; Schiff D; Mehnert JM; Goydos JS; Chen S; Haffty BG
Clin Cancer Res; 2011 Apr; 17(7):1807-14. PubMed ID: 21325066
[TBL] [Abstract][Full Text] [Related]
5. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
Li H; Ma L; Bian X; Lv Y; Lin W
Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
[TBL] [Abstract][Full Text] [Related]
6. The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer.
Ma L; Bian X; Lin W
J Exp Clin Cancer Res; 2020 Oct; 39(1):219. PubMed ID: 33069237
[TBL] [Abstract][Full Text] [Related]
7. CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer.
Ran X; Wu BX; Shi M; Song L; Nixon K; Philip V; He HH; Tsao MS; Lok BH
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1308-1314. PubMed ID: 38104868
[TBL] [Abstract][Full Text] [Related]
8. Enantiomeric resolution of albendazole sulfoxide by semipreparative HPLC and in vitro study of growth inhibitory effects on human cancer cell lines.
Belaz KR; Denadai M; Almeida AP; Lima RT; Vasconcelos MH; Pinto MM; Cass QB; Oliveira RV
J Pharm Biomed Anal; 2012 Jul; 66():100-8. PubMed ID: 22487592
[TBL] [Abstract][Full Text] [Related]
9. Albendazole as a promising molecule for tumor control.
Castro LS; Kviecinski MR; Ourique F; Parisotto EB; Grinevicius VM; Correia JF; Wilhelm Filho D; Pedrosa RC
Redox Biol; 2016 Dec; 10():90-99. PubMed ID: 27710854
[TBL] [Abstract][Full Text] [Related]
10. Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.
Baker AF; Hanke NT; Sands BJ; Carbajal L; Anderl JL; Garland LL
J Exp Clin Cancer Res; 2014 Dec; 33(1):111. PubMed ID: 25612802
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis.
Pourgholami MH; Akhter J; Wang L; Lu Y; Morris DL
Cancer Chemother Pharmacol; 2005 May; 55(5):425-32. PubMed ID: 15565325
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis.
Bruzzese F; Rocco M; Castelli S; Di Gennaro E; Desideri A; Budillon A
Mol Cancer Ther; 2009 Nov; 8(11):3075-87. PubMed ID: 19887547
[TBL] [Abstract][Full Text] [Related]
13. Albendazole inhibits HIF-1α-dependent glycolysis and VEGF expression in non-small cell lung cancer cells.
Zhou F; Du J; Wang J
Mol Cell Biochem; 2017 Apr; 428(1-2):171-178. PubMed ID: 28063005
[TBL] [Abstract][Full Text] [Related]
14. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
[TBL] [Abstract][Full Text] [Related]
15. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Shafer SH; Williams CL
Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
[TBL] [Abstract][Full Text] [Related]
16. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L
Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
[TBL] [Abstract][Full Text] [Related]
18. Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy.
Zhang W; He Z; Liang F; Gong J; Tan L; Yang J; Song S; Xie L; Lu Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16763-16778. PubMed ID: 37730912
[TBL] [Abstract][Full Text] [Related]
19. A Soft Coral-Derived Compound, 11-Dehydrosinulariolide, Induces G2/M Cell Cycle Arrest and Apoptosis in Small Cell Lung Cancer.
Lin YC; Su JH; Lin SC; Chang CC; Hsia TC; Tung YT; Lin CC
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30513611
[TBL] [Abstract][Full Text] [Related]
20. The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer.
Li H; Wang H; Deng K; Han W; Hong B; Lin W
Cancer Biomark; 2019; 24(1):51-59. PubMed ID: 30614795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]